Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $255.74M | $145.82M | +75.38% |
Operating Income | $-68.69M | $-53.27M | -28.94% |
Net Income | $-68.04M | $-64.74M | -5.09% |
EPS (Basic) | $-0.40 | $-1.47 | +72.79% |
EPS (Diluted) | $-0.40 | $-1.47 | +72.79% |
R&D Expense | $35.87M | $24.34M | +47.39% |
SG&A Expense | $154.63M | $79.56M | +94.34% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.54B | — | — |
Current Assets | $573.97M | — | — |
Total Liabilities | $1.22B | — | — |
Current Liabilities | $336.47M | — | — |
Stockholders' Equity | $326.19M | $-1.47B | +122.12% |
Cash & Equivalents | $151.6M | $79.94M | +89.64% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-105.62M | $-101.38M | -4.19% |
Investing Cash Flow | $-375.82M | $16.99M | -2312.00% |
Financing Cash Flow | $293.04M | $-1.38M | +21365.75% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -26.9% | -36.5% | +9.67% |
Net Margin | -26.6% | — | — |
ROE | -20.9% | — | — |
ROA | -4.4% | — | — |
Current Ratio | $1.706 | — | — |
Debt to Equity | $3.731 | — | — |
Other companies in Life Sciences Tools & Services